Edward M Alderman

Title: Edward M Alderman: Innovator in Immunotherapy

Introduction

Edward M Alderman is a notable inventor based in Dedham, MA (US). He has made significant contributions to the field of immunotherapy, holding a total of 3 patents. His work focuses on innovative methods to combat diseases through the use of antibodies.

Latest Patents

One of Alderman's latest patents is titled "Antibodies to angiogenin: immunotherapeutic agents." This invention pertains to the production of antibodies that target angiogenin or its fragments. It outlines methods for inhibiting angiogenesis in mammals by administering these antibodies or their fragments, thereby reducing angiogenic activity. Additionally, this patent includes pharmaceutical compositions that contain therapeutically effective amounts of antibodies that are immunologically reactive with angiogenin.

Another significant patent is the "Method of isolating tumor-secreted products using a novel protein-free medium." This invention describes a medium designed for the maintenance of mammalian anchorage-dependent colonic adenocarcinoma cells. The medium consists of buffered salts, L-glutamine, and glucose, and is devoid of exogenous protein, while also including a solution of amino acids.

Career Highlights

Edward M Alderman is affiliated with Harvard College, where he continues to contribute to research and innovation in his field. His work has been instrumental in advancing the understanding of immunotherapeutic agents and their applications in medicine.

Collaborations

Alderman has collaborated with notable colleagues such as James W Fett and Bert L Vallee. These partnerships have further enriched his research and development efforts in immunotherapy.

Conclusion

Edward M Alderman's innovative work in the field of immunotherapy has led to significant advancements in the production of antibodies and their applications in medicine. His contributions continue to impact the scientific community and pave the way for future research.